These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

636 related articles for article (PubMed ID: 29232923)

  • 1. An Oldie but Goodie: Lithium in the Treatment of Bipolar Disorder through Neuroprotective and Neurotrophic Mechanisms.
    Won E; Kim YK
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29232923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium, Stress, and Resilience in Bipolar Disorder: Deciphering this key homeostatic synaptic plasticity regulator.
    Machado-Vieira R
    J Affect Disord; 2018 Jun; 233():92-99. PubMed ID: 29310970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms underlying mood stabilization in manic-depressive illness: the phenotype challenge.
    Ikonomov OC; Manji HK
    Am J Psychiatry; 1999 Oct; 156(10):1506-14. PubMed ID: 10518159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness.
    Manji HK; Moore GJ; Chen G
    J Clin Psychiatry; 2000; 61 Suppl 9():82-96. PubMed ID: 10826666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis.
    Machado-Vieira R; Manji HK; Zarate CA
    Bipolar Disord; 2009 Jun; 11 Suppl 2(Suppl 2):92-109. PubMed ID: 19538689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder.
    Dandekar MP; Valvassori SS; Dal-Pont GC; Quevedo J
    Curr Drug Metab; 2018; 19(8):663-673. PubMed ID: 29283064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder.
    Soeiro-de-Souza MG; Dias VV; Figueira ML; Forlenza OV; Gattaz WF; Zarate CA; Machado-Vieira R
    Acta Psychiatr Scand; 2012 Nov; 126(5):332-41. PubMed ID: 22676371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Advances in the Pharmacology and Toxicology of Lithium: A Neurobiologically Oriented Overview.
    Bortolozzi A; Fico G; Berk M; Solmi M; Fornaro M; Quevedo J; Zarate CA; Kessing LV; Vieta E; Carvalho AF
    Pharmacol Rev; 2024 May; 76(3):323-357. PubMed ID: 38697859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Mechanisms of Lithium in Bipolar Disorder: Recent Advances and Current Understanding.
    Malhi GS; Outhred T
    CNS Drugs; 2016 Oct; 30(10):931-49. PubMed ID: 27638546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium as a Neuroprotective Agent for Bipolar Disorder: An Overview.
    Ochoa ELM
    Cell Mol Neurobiol; 2022 Jan; 42(1):85-97. PubMed ID: 34357564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen synthase kinase 3beta as a likely target for the action of lithium on circadian clocks.
    Padiath QS; Paranjpe D; Jain S; Sharma VK
    Chronobiol Int; 2004 Jan; 21(1):43-55. PubMed ID: 15129823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithium-associated transcriptional regulation of CRMP1 in patient-derived olfactory neurons and symptom changes in bipolar disorder.
    McLean CK; Narayan S; Lin SY; Rai N; Chung Y; Hipolito MS; Cascella NG; Nurnberger JI; Ishizuka K; Sawa AS; Nwulia EA
    Transl Psychiatry; 2018 Apr; 8(1):81. PubMed ID: 29666369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium-induced neuroprotective activity in neuronal and microglial cells: A purinergic perspective.
    Gubert C; Andrejew R; Figueiro F; Bergamin L; Kapczinski F; Magalhães PVDS; Battastini AMO
    Psychiatry Res; 2021 Jan; 295():113562. PubMed ID: 33213934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why is lithium effective in alleviating bipolar disorder?
    Sato K
    Med Hypotheses; 2021 Feb; 147():110484. PubMed ID: 33444905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A systematic analysis of neurobiological roles of lithium].
    Gogoleva IV; Gromova OA; Torshin IY; Grishina TR; Pronin AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(11):17-23. PubMed ID: 36440772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders.
    Chiu CT; Chuang DM
    Pharmacol Ther; 2010 Nov; 128(2):281-304. PubMed ID: 20705090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium neuroprotection: molecular mechanisms and clinical implications.
    Rowe MK; Chuang DM
    Expert Rev Mol Med; 2004 Oct; 6(21):1-18. PubMed ID: 15488156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium and GSK-3β promoter gene variants influence cortical gray matter volumes in bipolar disorder.
    Benedetti F; Poletti S; Radaelli D; Locatelli C; Pirovano A; Lorenzi C; Vai B; Bollettini I; Falini A; Smeraldi E; Colombo C
    Psychopharmacology (Berl); 2015 Apr; 232(7):1325-36. PubMed ID: 25345732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogen synthase kinase-3β activity and cognitive functioning in patients with bipolar I disorder.
    Munkholm K; Miskowiak KW; Jacoby AS; Vinberg M; Leme Talib L; Gattaz WF; Kessing LV
    Eur Neuropsychopharmacol; 2018 Mar; 28(3):361-368. PubMed ID: 29433844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal transduction pathways. Molecular targets for lithium's actions.
    Manji HK; Potter WZ; Lenox RH
    Arch Gen Psychiatry; 1995 Jul; 52(7):531-43. PubMed ID: 7598629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.